Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.
Share with a colleague
Pharmaceutical Executive Europe  E-News
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecutive
 
Survey
We asked 40 pharma professionals, What is the biggest threat to industry in the
next five years

Lack of innovation 66%
Poor pricing and uptake 17%
Regulation 17%

Talk to us:
jupton@advanstar.com

Advertise with us:
wblow@advanstar.com

7 January, 2014
Pharm Exec Global Digest Social Media Special
In the latest issue of Pharm Exec Global Digest: Has Pharma Finally ‘Got’ Social Media? — Five Ways Advanced Social Intelligence Can Guide Pharma Strategy ­­— Preparing for Crisis in an ‘Always On’ Digital Word — and more ...View here
Best of the Blog: Pharm Exec’s 10 Most Read Stories of 2013
We at PharmExec are looking forward to a busy and hopefully fortuitous 2014. Looking back on 2013, here are the 10 most-read stories published on PharmExec’s blog during the year, in case you missed them ... Read more
Europe's New Clinical Trials Rules: Questions Remain over Data Transparency
Although a broad compromise was reached in late December on the future shape of the European Union’s clinical trials rules, there are still many details to be resolved — including on that perennial issue of data transparency ... Read more
2014: The Year of Digital Pharma?
2014 might be the year that pharma finally has to get really serious about digital, at least if analysts at Forrester Research are right. Peter Houston reports ... Read more
Tracking Innovation in 2013’s New Molecular Entitities
Patricia Van Arnum reviews 2013's crop of the new molecular entities and new biologics license applications approved by FDA ... Read more
Product Profile
Sciformix
Product labeling– Increasing efficiency, enhancing quality, and delivering compliance
Pharmaceutical product labeling is a highly regulated and complex process. A product label is very specific in its content, with respect to safety data, adverse effects and compliance to country specific regulations. Read more.
Also in this issue
Infectious Disease Focus Leaving Child Cancer Exposed in Developing Countries
Climate Change in Outsourcing
Pharm Exec Round Table on Market Access